Randall B. Brenner, Chief Development & Regulatory at Paratek Pharmaceuticals, Inc. (PRTK), sold 3,516 shares at $3.47 ($12K) on 2022-10-28, disclosed to the SEC on 2022-11-01.
Scheduled sale ($12k) by Chief Development & Regulatory under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRTK | SELL | 2022-12-14 | $58K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $104K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $188K | — | Filing → |